why choose us

First received: October 27, 2022

Clinical Trial: A Dose Escalation Study of Levetiracetam in the Treatment of Neonatal Seizures

Study Status: Completed

Recruit Status: RECRUITING

Condition: Neonatal Seizure

Study Type: INTERVENTIONAL


Official Title: A Phase IIb Dose Escalation Study of Levetiracetam for the Treatment of Neonatal Seizures

Brief Summary: The main purpose of this study is to determine the maximum safe tolerated dose of LEV in the treatment of neonatal seizures.Our hypothesis is that optimal dosing of Levetiracetam (LEV) to treat neonatal seizures is significantly greater than 60mg/kg.This study will be an open label dose-escalation, preliminary safety and efficacy study.There will be a randomized control treatment component.Infants recognized as having neonatal seizures or as being at risk of developing seizures will be recruited and started…

Read more